{
    "nctId": "NCT00807924",
    "briefTitle": "American Breast Laser Ablation Therapy Evaluation",
    "officialTitle": "American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase\u2122 Breast Interstitial Laser Therapy in Real World Application",
    "overallStatus": "COMPLETED",
    "conditions": "Benign Breast Conditions; Breast Fibroadenomas",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 108,
    "primaryOutcomeMeasure": "To monitor and measure long term safety and effectiveness Novilase",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis confirmed by needle core biopsy\n* Tumors detected either by physical exam or imaging\n* Tumors do not exceed 2 cm in diameter and measure at least 0.5 cm away from the skin and chest wall\n* Single, multiple and/or bilateral tumors\n* Patient has given consent prior to being treated with Novilase\u2122\n\nExclusion Criteria:\n\n* Patient is pregnant or lactating\n* Hypercellularity suggestive of phyllodes\n* Atypia\n* Equivocal pathology report (e.g., discordance between radiographic and microscopic results)\n* Fibroadenomas with stromal solidarity",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}